Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Chemours Company (NY: CC )

17.82 -0.34 (-1.87%)
Official Closing Price Updated: 7:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Chemours Company

< Previous 1 2
...
11 12 13 14 15 16 17 18 Next >
Chemours Announces Joint Venture Agreement with BWT to Enable the Capacity and Innovation Required by the Transportation Fuel Cell Market
From The Chemours Company
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For October 5, 2022
Upgrades 
Via Benzinga
Expert Ratings for Chemours
Analysts have provided the following ratings for Chemours (NYSE:CC) within the last quarter: 
Via Benzinga
3 Undervalued Cruise Stocks to Buy Now
These undervalued cruise stocks have bounced back exceedingly well from the pandemic-led weakness and are benefitting from pent-up demand. 
Via InvestorPlace
Chemours Announces Dates for Third Quarter 2022 Earnings Release and Webcast Conference Call
From The Chemours Company
Via Business Wire
Chemours Announces $200 Million Investment to Expand Capacity and Technology in Response to Growing Global Demand for Hydrogen Solutions
From The Chemours Company
Via Business Wire
McDonald's Price Target Cut By This Analyst, Plus Cowen Predicts $362 For Domino's Pizza
Citigroup cut McDonald's Corporation (NYSE: MCD) price target from $275 to $246. McDonald's shares rose 0.5% to $245.00 in pre-market trading. 
Via Benzinga
Spero Therapeutics To Rally Around 240%? Plus This Analyst Slashes PT On Salesforce
Evercore ISI Group raised the price target on Spero Therapeutics, Inc. (NASDAQ: SPRO) from $2 to $8. Evercore ISI Group analyst Josh Schimmer also upgraded the stock from In-Line to Outperform. Spero... 
Via Benzinga
UnitedHealth To Rally 24%? Here Are 5 Other Price Target Changes For Thursday
Raymond James raised the price target on UnitedHealth Group Incorporated (NYSE: UNH) from $620 to $635. Raymond James analyst John Ransom maintained the stock with a Strong Buy rating. UnitedHealth... 
Via Benzinga
Chemours Commends the U.S. Senate for Ratification of the Kigali Amendment
From The Chemours Company
Via Business Wire
Chemours, Alcoa And Other Big Losers From Wednesday
U.S. stocks closed lower with the Dow Jones dropping more than 500 points on Tuesday. Here is the list of some big stocks recording losses in the previous session. 
Via Benzinga
The Chemours Company Provides Update on Full Year 2022 Guidance
From The Chemours Company
Via Business Wire
Chemours Washington Works Awards Four Local Students with Scholarships
From The Chemours Company
Via Business Wire
Chemours Titanium Technologies Announces Second Annual Carrier of the Year Award
From The Chemours Company
Via Business Wire
West Virginia State University and Chemours Partner to Advance Chemistry and Chemical Engineering Education
From The Chemours Company and West Virginia State University
Via Business Wire
The Chemours Company Announces Promotion of Kristine Wellman to Senior Vice President, General Counsel & Corporate Secretary, as Dave Shelton Announces Retirement and Moves to Role as Special Counsel to the CEO
From The Chemours Company
Via Business Wire
Chemours Begins Commissioning at Its Newest Sand Mine in Clay County, Florida
From The Chemours Company
Via Business Wire
Chemours Details Progress in its Fifth Corporate Responsibility Commitment Report
From The Chemours Company
Via Business Wire
Chemours Takes the Next Step in its ESG and Sustainability Journey; Commits to Set Science-Based Emissions Reduction Targets
From The Chemours Company
Via Business Wire
UBS Maintains Neutral Rating for Chemours: Here's What You Need To Know
UBS has decided to maintain its Neutral rating of Chemours (NYSE:CC) and raise its price target from $35.00 to $37.00. Shares of Chemours are trading up 3.55% over the last 24 hours, at $36.14 per... 
Via Benzinga
5 Analysts Have This to Say About Chemours
Over the past 3 months, 5 analysts have published their opinion on Chemours (NYSE:CC) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's... 
Via Benzinga
Recap: Chemours Q2 Earnings
Chemours (NYSE:CC) reported its Q2 earnings results on Thursday, July 28, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Chemours beat estimated earnings by... 
Via Benzinga
Chemours to Expand Opteon™ Capacity in Texas to Meet Growing Customer Needs for Low GWP Solutions
From The Chemours Company
Via Business Wire
The Chemours Company Reports Robust Second Quarter 2022 Results
From The Chemours Company
Via Business Wire
Chemours Announces Third Quarter Dividend
From The Chemours Company
Via Business Wire
Chemours Earns Great Place to Work Certification™ in the United States
From The Chemours Company
Via Business Wire
How Does The Need Of Marketization Of HFCVs Impact PEM Industry?
As carbon neutral is becoming a consensus, the marketization of HFCVs is accelerating all over the world with its zero-carbon emission. 
Via Talk Markets
Chemours, Emerson, and Hussmann Earn Top Project of the Year Award from Environment + Energy Leader
From The Chemours Company
Via Business Wire
Chemours CEO and Chief Brand Officer Recognized as Two of the Most Influential Black Executives in Corporate America by Savoy Magazine
From The Chemours Company
Via Business Wire
Chemours Announces Dates for Second Quarter 2022 Earnings Release and Webcast Conference Call
From The Chemours Company
Via Business Wire
< Previous 1 2
...
11 12 13 14 15 16 17 18 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.